| A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease DJ Laderach, LD Gentilini, L Giribaldi, VC Delgado, L Nugnes, DO Croci, ... Cancer research 73 (1), 86-96, 2013 | 192 | 2013 |
| Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8 VMC Delgado, LG Nugnes, LL Colombo, MF Troncoso, MM Fernández, ... The FASEB Journal 25 (1), 242-254, 2011 | 172 | 2011 |
| RGS16 is a negative regulator of SDF-1–CXCR4 signaling in megakaryocytes M Berthebaud, C Riviere, P Jarrier, A Foudi, Y Zhang, D Compagno, ... Blood 106 (9), 2962-2968, 2005 | 119 | 2005 |
| RNA interference shows critical requirement for NF-κB p50 in the production of IL-12 by human dendritic cells D Laderach, D Compagno, O Danos, W Vainchenker, A Galy The Journal of Immunology 171 (4), 1750-1757, 2003 | 114 | 2003 |
| Galectin‐1 triggers epithelial‐mesenchymal transition in human hepatocellular carcinoma cells ML Bacigalupo, M Manzi, MV Espelt, LD Gentilini, D Compagno, ... Journal of cellular physiology 230 (6), 1298-1309, 2015 | 84 | 2015 |
| Galectin-8: a matricellular lectin with key roles in angiogenesis MF Troncoso, F Ferragut, ML Bacigalupo, VM Cárdenas Delgado, ... Glycobiology 24 (10), 907-914, 2014 | 83 | 2014 |
| SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas D Compagno, C Merle, A Morin, C Gilbert, JRR Mathieu, A Bozec, ... PLoS One 2 (10), e1006, 2007 | 76 | 2007 |
| Galectins: major signaling modulators inside and outside the cell D Compagno, FM Jaworski, L Gentilini, G Contrufo, IG Pérez, MT Elola, ... Current molecular medicine 14 (5), 630-651, 2014 | 68 | 2014 |
| Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings DJ Laderach, D Compagno, MA Toscano, DO Croci, S Dergan‐Dylon, ... Iubmb Life 62 (1), 1-13, 2010 | 65 | 2010 |
| A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells A Olivier, L Jeanson-Leh, G Bouma, D Compagno, J Blondeau, K Seye, ... Molecular Therapy 13 (4), 729-737, 2006 | 65 | 2006 |
| Glycans and galectins in prostate cancer biology, angiogenesis and metastasis D Compagno, LD Gentilini, FM Jaworski, IG Pérez, G Contrufo, ... Glycobiology 24 (10), 899-906, 2014 | 61 | 2014 |
| Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors MT Elola, F Ferragut, VM Cardenas Delgado, LG Nugnes, L Gentilini, ... F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de …, 2014 | 54 | 2014 |
| Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer LD Gentilini, FM Jaworski, C Tiraboschi, IG Pérez, ML Kotler, ... Oncotarget 8 (27), 44654, 2017 | 48 | 2017 |
| Galectins as checkpoints of the immune system in cancers, their clinical relevance, and implication in clinical trials D Compagno, C Tiraboschi, JD Garcia, Y Rondón, E Corapi, C Velazquez, ... Biomolecules 10 (5), 750, 2020 | 45 | 2020 |
| Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin D Compagno, JN Lampe, C Bourget, IV Kutyavin, L Yurchenko, ... Journal of Biological Chemistry 274 (12), 8191-8198, 1999 | 36 | 1999 |
| Dok-4 is a novel negative regulator of T cell activation A Gérard, M Ghiotto, C Fos, G Guittard, D Compagno, A Galy, S Lemay, ... The Journal of Immunology 182 (12), 7681-7689, 2009 | 32 | 2009 |
| Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer A Chauchereau, N Al Nakouzi, C Gaudin, S Le Moulec, D Compagno, ... Experimental cell research 317 (3), 262-275, 2011 | 31 | 2011 |
| Endogenous galectin-1 in T lymphocytes regulates anti-prostate cancer immunity E Corapi, G Carrizo, D Compagno, D Laderach Frontiers in immunology 9, 405659, 2018 | 28 | 2018 |
| In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development FM Jaworski, LD Gentilini, G Gueron, RP Meiss, EG Ortiz, PM Berguer, ... Clinical Cancer Research 23 (17), 5135-5148, 2017 | 27 | 2017 |
| Delineating the" galectin signature" of the tumor microenvironment D Compagno, DJ Laderach, L Gentilini, FM Jaworski, GA Rabinovich Oncoimmunology 2 (4), e23565, 2013 | 22 | 2013 |
